Brief: Tianjin Development Says HY Net Profit Attributable Of Tianjin Lisheng Pharmaceutical RMB61.3 Mln
24/08/2021 07:23
Aug 24 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* HY NET PROFIT ATTRIBUTABLE OF TIANJIN LISHENG
PHARMACEUTICAL
RMB61.3 MILLION VERSUS RMB56.6 MILLION
* HY TOTAL OPERATING INCOME FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB587.3 MILLION VERSUS RMB613.9 MILLION
Source text for Eikon: ID:nHKS4wnCYq
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln